Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B [Phase 2]

View source ↗

Summary

A Phase IIa randomized, double-blind, placebo-controlled trial is evaluating the safety and efficacy of GST-HG131 tablets in adults with chronic hepatitis B and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• GST-HG131 tablets (GST-HG131)

Snippet

Sponsor: Fujian Akeylink Biotechnology Co., Ltd. | Conditions: Chronic Hepatitis B | Phase 2 | Status: RECRUITING